FDA Expands Clearance of Cryoablation Technology for Kidney, Liver, Head and Neck Tumors
The US Food and Drug Administration has expanded the clearance of a cryoablation technology platform for the treatment of cancerous and benign tumors of the kidney, liver, ear, nose or throat, according to a press release from the product’s manufacturer.





